CU-05

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameCU-05
Drug Alias NameCU-05CU05
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPI3-kinase class I inhibitorsProto-oncogene proteins c-akt inhibitors
TargetsPI3-kinase class IProto-oncogene proteins c-akt
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCuracle Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCuracle Co Ltd
Inactive CompaniesN/A
Active IndicationsLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A